|
Association of long-term survival in pancreatic cancer (PDAC) with increased proliferative and anti-apoptotic protein activation. |
| |
|
Stock and Other Ownership Interests - Abbvie; Amgen; Johnson & Johnson |
|
Consulting or Advisory Role - Halozyme; Taiho Pharmaceutical |
Research Funding - Aduro Biotech; Clovis Oncology; FibroGen; Immunomedics; Incyte; OncoMed; Theranostics Health |
| |
|
No Relationships to Disclose |
| |
|
Employment - Theranostics Health |
| |
|
Employment - Theranostics Health |
Leadership - Theranostics Health |
Research Funding - Theranostics Health |
Patents, Royalties, Other Intellectual Property - Dyad Pharmaceuticals; Isis Pharmaceuticals |
Travel, Accommodations, Expenses - Theranostics Health |